These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 17230050

  • 1. Cue exposure therapy for the treatment of opiate addiction: results of a randomized controlled clinical trial.
    Marissen MA, Franken IH, Blanken P, van den Brink W, Hendriks VM.
    Psychother Psychosom; 2007; 76(2):97-105. PubMed ID: 17230050
    [Abstract] [Full Text] [Related]

  • 2. Attentional bias predicts heroin relapse following treatment.
    Marissen MA, Franken IH, Waters AJ, Blanken P, van den Brink W, Hendriks VM.
    Addiction; 2006 Sep; 101(9):1306-12. PubMed ID: 16911730
    [Abstract] [Full Text] [Related]

  • 3. Diurnal variation in cue-induced responses among protracted abstinent heroin users.
    Ren ZY, Zhang XL, Liu Y, Zhao LY, Shi J, Bao Y, Zhang XY, Kosten TR, Lu L.
    Pharmacol Biochem Behav; 2009 Jan; 91(3):468-72. PubMed ID: 18809427
    [Abstract] [Full Text] [Related]

  • 4. Immersive virtual environments in cue exposure.
    Kuntze MF, Stoermer R, Mager R, Roessler A, Mueller-Spahn F, Bullinger AH.
    Cyberpsychol Behav; 2001 Aug; 4(4):497-501. PubMed ID: 11708729
    [Abstract] [Full Text] [Related]

  • 5. Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts.
    Shi J, Jun W, Zhao LY, Xue YX, Zhang XY, Kosten TR, Lu L.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):108-12. PubMed ID: 19470385
    [Abstract] [Full Text] [Related]

  • 6. Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
    Krupitsky EM, Zvartau EE, Masalov DV, Tsoy MV, Burakov AM, Egorova VY, Didenko TY, Romanova TN, Ivanova EB, Bespalov AY, Verbitskaya EV, Neznanov NG, Grinenko AY, O'Brien CP, Woody GE.
    J Subst Abuse Treat; 2006 Dec 01; 31(4):319-28. PubMed ID: 17084785
    [Abstract] [Full Text] [Related]

  • 7. Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers.
    Shi J, Zhao LY, Epstein DH, Zhang XL, Lu L.
    Pharmacol Biochem Behav; 2007 May 01; 87(1):141-5. PubMed ID: 17532034
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiological evidence of the motivational salience of drug cues in opiate addiction.
    Lubman DI, Allen NB, Peters LA, Deakin JF.
    Psychol Med; 2007 Aug 01; 37(8):1203-9. PubMed ID: 17274853
    [Abstract] [Full Text] [Related]

  • 9. Determinants of cue-elicited craving and physiologic reactivity in methamphetamine-dependent subjects in the laboratory.
    Tolliver BK, McRae-Clark AL, Saladin M, Price KL, Simpson AN, DeSantis SM, Baker NL, Brady KT.
    Am J Drug Alcohol Abuse; 2010 Mar 01; 36(2):106-13. PubMed ID: 20337507
    [Abstract] [Full Text] [Related]

  • 10. Postwithdrawal exposure treatment to prevent relapse in opiate addicts: a pilot study.
    Kasvikis Y, Bradley B, Powell J, Marks I, Gray JA.
    Int J Addict; 1991 Nov 01; 26(11):1187-95. PubMed ID: 1683860
    [Abstract] [Full Text] [Related]

  • 11. Biofeedback combined with cue-exposure as a treatment for heroin addicts.
    Du J, Fan C, Jiang H, Sun H, Li X, Zhao M.
    Physiol Behav; 2014 May 10; 130():34-9. PubMed ID: 24631304
    [Abstract] [Full Text] [Related]

  • 12. Gender and stimulus difference in cue-induced responses in abstinent heroin users.
    Yu J, Zhang S, Epstein DH, Fang Y, Shi J, Qin H, Yao S, Le Foll B, Lu L.
    Pharmacol Biochem Behav; 2007 Mar 10; 86(3):485-92. PubMed ID: 17306353
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Meta-analysis of cue-reactivity in addiction research.
    Carter BL, Tiffany ST.
    Addiction; 1999 Mar 10; 94(3):327-40. PubMed ID: 10605857
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Suppression of cue-induced heroin craving and cue-reactivity by single-trial transcutaneous electrical nerve stimulation at 2 Hz.
    Zhong F, Wu LZ, Han JS.
    Addict Biol; 2006 Jun 10; 11(2):184-9. PubMed ID: 16800833
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gender differences in cue exposure reactivity and 9-month outcome.
    Sterling RC, Dean J, Weinstein SP, Murphy J, Gottheil E.
    J Subst Abuse Treat; 2004 Jul 10; 27(1):39-44. PubMed ID: 15223092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.